| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/15/2006 | WO2006061846A1 Pharmaceutical composition for improving palatability of drugs and process for preparation thereof |
| 06/15/2006 | WO2006061827A1 Microemulsion comprising carbamazepine having solubility |
| 06/15/2006 | WO2006061716A1 Pharmaceutical formulation comprising low crystallinity cellulose |
| 06/15/2006 | WO2006061697A1 Sulfonylurea compositions and a process for its preparation |
| 06/15/2006 | WO2006061689A1 Topical drug delivery system |
| 06/15/2006 | WO2006061596A1 Linseed eye compresses |
| 06/15/2006 | WO2006061502A1 Tablets for the sustained release of indapamide and preparation method thereof |
| 06/15/2006 | WO2006061351A1 Oral suspension comprising meloxicam |
| 06/15/2006 | WO2006061340A2 Stable, hormone-containing (intermediate) product |
| 06/15/2006 | WO2006061336A2 Oral compositions for absorption of phosphorus compounds |
| 06/15/2006 | WO2006061156A2 Medicament for hygienic application inside the ear |
| 06/15/2006 | WO2006061142A1 Orally dispersible pharmaceutical composition and process for the preparation thereof |
| 06/15/2006 | WO2006061069A1 Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing said form of administration |
| 06/15/2006 | WO2006042324A3 Antifungal composition applicable to body tissue, preferably nails |
| 06/15/2006 | WO2006039692A3 Modified release ibuprofen dosage form |
| 06/15/2006 | WO2006031857A3 Delivering iron to an animal |
| 06/15/2006 | WO2006031584A3 Quick dissolve medicament and method of manufacturing |
| 06/15/2006 | WO2006031391A3 Method and device for the delivery of a substance including a covering |
| 06/15/2006 | WO2006026840A3 Controlled release delivery system for bio-active agents |
| 06/15/2006 | WO2006023035A3 Improved stearate composition and method of production thereof |
| 06/15/2006 | WO2006020180A3 Implantable devices and methods for delivering drugs and other substances to treat sinusitis and other disorders |
| 06/15/2006 | WO2006015299A9 Multi-reservoir device for transdermal drug delivery and sensing |
| 06/15/2006 | WO2006013369A3 Compositions forming non-lamellar dispersions |
| 06/15/2006 | WO2006007662A8 Methods for increasing foam stability |
| 06/15/2006 | WO2006007323A3 Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents |
| 06/15/2006 | WO2005123903A3 Culture aid for cells and tissues |
| 06/15/2006 | WO2005123076A3 Pharmaceutical compositions |
| 06/15/2006 | WO2005112958A3 Rapid setting calcium phosphate cements |
| 06/15/2006 | WO2005110436A3 Macromolecule-containing sustained release intraocular implants and related methods |
| 06/15/2006 | WO2005110376A3 Rapidly disintegrating tablets comprising titanium dioxide |
| 06/15/2006 | WO2005107679A3 Protective microcontainers |
| 06/15/2006 | WO2005102269A3 An amine drug-containing slow-release granule preparation based on particles with a coating layer and the corresponding method of production |
| 06/15/2006 | WO2005092380A3 Uses of anti-ctla-4 antibodies |
| 06/15/2006 | WO2005087192A3 Salmeterol inhalation formulations |
| 06/15/2006 | WO2005084638A3 Formulations decreasing infectivity of pulmonary diseases |
| 06/15/2006 | WO2005080433A3 Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity |
| 06/15/2006 | WO2005079759A3 Pharmaceutical composition for oral application and method for preparing thereof |
| 06/15/2006 | WO2005074882A3 Flat system for using in the oral cavity |
| 06/15/2006 | WO2005073246A3 Method for preparing kl4 lung surfactant |
| 06/15/2006 | WO2005063211A3 Method of producing lipid complexed camptothecin-carboxylate |
| 06/15/2006 | WO2005023176A3 Delivery of physiologixal agents with in-situ gels comprising anionic polysaccharides |
| 06/15/2006 | WO2005007134A8 Powdery formulations for inhalation, containing a novel anticholinergic agent |
| 06/15/2006 | WO2004052336A3 High viscosity liquid controlled delivery system and medical or surgical device |
| 06/15/2006 | WO2004019890A3 In vivo production of cyclic peptides for inhibiting protein-protein interaction |
| 06/15/2006 | US20060129429 Clinical assessment and diagnostic tool for use with peristaltic pump |
| 06/15/2006 | US20060129139 Osmotic delivery system having space efficient piston |
| 06/15/2006 | US20060129138 Drug delivery system |
| 06/15/2006 | US20060128993 Used to treat mood (depression), anxiety (obsessive compulsive disorder), behavioral, eating, substance abuse and sexual disorders and for prevention of migraines; (1S,4R)-N-[4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine |
| 06/15/2006 | US20060128947 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 06/15/2006 | US20060128938 Lactic acid polymer and process for producing the same |
| 06/15/2006 | US20060128918 Partially biodegradable temperature and ph sensitive hydrogel |
| 06/15/2006 | US20060128806 Controlled release arginine alpha-ketoglutarate |
| 06/15/2006 | US20060128736 Camptothecin-carboxylate formulations |
| 06/15/2006 | US20060128656 Charged phospholipid compositions and methods for their use |
| 06/15/2006 | US20060128655 Use of hyaluronic acid or its derivatives to enhance delivery of antineoplastic agents |
| 06/15/2006 | US20060128625 A growth factor formulation comprising: a polypeptide of the TGF- beta (tranformation growth factor) superfamily, N-vinyl-2-pyrrolidone polymer carrier and a solvent selected from water and aqueous buffer solutions |
| 06/15/2006 | US20060128621 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use |
| 06/15/2006 | US20060127873 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors |
| 06/15/2006 | US20060127499 Vitamin-mineral compositions |
| 06/15/2006 | US20060127491 By administering emulsion containing fish oil derived omega-3-fatty acid; free of phytosterols and plant derived fatty acids |
| 06/15/2006 | US20060127490 Liquid core capsules and methods of synthesis thereof through interfacial polymerization |
| 06/15/2006 | US20060127489 Targeted delivery |
| 06/15/2006 | US20060127488 Process of making flowable hemostatic compositions and devices containing such compositions |
| 06/15/2006 | US20060127487 Antiviral compositions |
| 06/15/2006 | US20060127486 Ceramic structures for prevention of drug diversion |
| 06/15/2006 | US20060127485 Bio-degradable colloid particles, in particular for pulmonary applications |
| 06/15/2006 | US20060127484 Controlled release composition |
| 06/15/2006 | US20060127483 Topical drug delivery system |
| 06/15/2006 | US20060127482 Combination of immuno gene therapy & chemotherapy for treatment of cancer & hyperproliferative diseases |
| 06/15/2006 | US20060127481 Ophthalmic drug delivery system using polymer micell |
| 06/15/2006 | US20060127480 Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof |
| 06/15/2006 | US20060127479 Solvent free taste masked pharmaceutical compositions |
| 06/15/2006 | US20060127478 Oral dosage formulation |
| 06/15/2006 | US20060127477 Novel preparation and administration form comprising an acid-labile active compound |
| 06/15/2006 | US20060127476 Delayed release oral dosage for side effect reduction of nausea, headache; improve patient compliance in treating menorrhagia; prevents a bolus release of tranexamic acid in the stomach |
| 06/15/2006 | US20060127475 tablet comprising disintegrant such as carmellose, sodium carboxymethyl starch, croscarmellose sodium, crospovidone, partly pregelatinized starch and low-substituted hydroxypropyl cellulose |
| 06/15/2006 | US20060127474 Pharmaceutical compositions comprising fluvastatin |
| 06/15/2006 | US20060127473 Compositions and methods for stabilizing active pharmaceutical ingredients |
| 06/15/2006 | US20060127472 Taste-masked prednisolone oral formulations |
| 06/15/2006 | US20060127471 Storage stable liposome; administering by injection; coupling with phosphatides and polyoxyethylene glycol |
| 06/15/2006 | US20060127470 Use of buckysome or carbon nanotube for drug delivery |
| 06/15/2006 | US20060127469 Entrapping in phosphatidylcholine component; room temperature transdermal delivery system; long shelf life |
| 06/15/2006 | US20060127468 Methods and related compositions for reduction of fat and skin tightening |
| 06/15/2006 | US20060127467 Nanoparticles for delivery of therapeutic agents using ultrasound and associated methods |
| 06/15/2006 | US20060127466 Method for transdermal or intradermal delivery of molecules |
| 06/15/2006 | US20060127465 Pad base for transdermal administration and needle |
| 06/15/2006 | US20060127464 Female hormone-containing patch |
| 06/15/2006 | US20060127459 Urogenital infection inhibition |
| 06/15/2006 | US20060127458 Single use personal care sheet |
| 06/15/2006 | US20060127457 Fabrics impregnated with antimicrobial agents |
| 06/15/2006 | US20060127456 Novel fiber-based consumer products based on new concepts of fiber modification |
| 06/15/2006 | US20060127453 Nutraceuticals and method of feeding aquatic animals |
| 06/15/2006 | US20060127451 Coating composition |
| 06/15/2006 | US20060127449 Method and composition for lowering cholesterol |
| 06/15/2006 | US20060127447 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 06/15/2006 | US20060127445 Anti-angiogenic compositions and methods of use |
| 06/15/2006 | US20060127440 Drug delivery systems for the prevention and treatment of vascular diseases |
| 06/15/2006 | US20060127423 Organic compounds |
| 06/15/2006 | US20060127422 Boron nitride particles of spherical geometry and process for making thereof |
| 06/15/2006 | US20060127421 Treatment using D-threo methylphenidate |